The conference is organized by Bionow, a membership organization for the life-sciences industry in the North of England, which offers a range of specialist business support services for the industry in the region. Though Bionow started off as a North West organization its website has recently announced an understanding with Science City York.
If you are a member of BioNW you can attend the conference for £72 + VAT (£63 + VAT if you are a premium member). For everybody else the cost is £90 + VAT.
The topics to be discussed include
- Venture capital and angel investment from Seroba Kernel
- Corporate venturing with Takeda and Astellas
- Public sector funding opportunities including a focus on the RGF
- Big pharma partnering with Eli Lilly and Merck
- Flotations with Mark Fahy of the Stock Exchange.
- Flotations with Mark Fahy of the Stock Exchange.
The delegates' list, which you can download from the conference website, contains some interesting names. If I had found out about it sooner I would have been there.
1 comment:
Here is a press comment http://www.thebusinessdesk.com/northwest/news/392902-venture-finance-isn-t-dead-yet-say-bioscience-investors.html?utm_source=newsletter&utm_medium=email&utm_campaign=NorthWest_7th_Nov_2012_-_Daily_E-mail
Post a Comment